Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education
Genetic Traits Linked to Fainting: What Your DNA Reveals
Fainting — the medical term is syncope — is a brief loss of consciousness caused by a sudden drop in blood flow to the brain. The most common form, vasovagal (reflex) syncope, happens when the autonomic nervous system overreacts to a trigger like standing too long, heat, pain, or the sight of blood, causing heart rate and blood pressure to fall. It runs in families, and researchers have begun to identify the genetic threads behind that tendency.
Why fainting clusters in families
Clinicians have long noticed that vasovagal syncope tends to run in families. Twin and family studies support a real inherited component: having a first-degree relative who faints meaningfully raises the odds that you do too. What is inherited is not fainting itself but the underlying autonomic reflex sensitivity — how readily your body triggers the drop in heart rate and vascular tone that ends in a faint.
The 2q32.1 signal: genetics of vasovagal syncope
A large genome-wide association study published in Neurology (Hadji-Turdeghal and colleagues, 2020) identified the first common genetic variant robustly linked to vasovagal syncope, located at chromosome 2q32.1 near the gene ZNF804A. The same locus has been implicated in blood-pressure regulation and neuropsychiatric traits, which fits the picture of syncope as a disorder sitting at the crossroads of cardiovascular control and nervous-system signaling.
Autonomic tone: adrenergic receptor genes
Because vasovagal syncope is fundamentally a failure of blood-pressure and heart-rate compensation, genes that shape autonomic signaling are of interest. Variants in the beta-adrenergic receptor genes ADRB1 and ADRB2 influence how blood vessels and the heart respond to adrenaline. Research links these to differences in baseline blood pressure and vascular reactivity — the same machinery that misfires during a vasovagal episode.
When fainting is a heart-rhythm signal, not a reflex
Most fainting is benign, but a smaller share reflects cardiac syncope, where an inherited heart-rhythm disorder is the cause. Channelopathy genes such as SCN5A (Brugada syndrome, cardiac sodium channel), KCNQ1, and KCNH2 (long QT syndrome) can trigger dangerous arrhythmias that present as fainting, sometimes during exertion or without warning. This is why fainting with exercise, a family history of sudden death, or an abnormal ECG always warrants prompt medical evaluation.
Prevention starts with understanding your triggers
For ordinary vasovagal syncope, evidence-based measures focus on recognizing warning signs and supporting blood volume and vascular tone: staying hydrated, adequate salt intake when a provider approves it, avoiding prolonged standing in heat, and using physical counter-pressure maneuvers — crossing and tensing the legs, or clenching the hands — at the first sign of lightheadedness. None of this replaces a medical work-up. A provider determines whether your fainting is reflex or cardiac, which changes everything about how it is managed.
What pathway-level genetic insight adds
The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, spanning cardiovascular and nervous-system signaling pathways that shape autonomic tone. It offers pathway-level context about your biology — it does not diagnose syncope, predict whether you will faint, or replace a cardiology evaluation. PlexusDx tells you about your biology; it does not tell you what to put in your body. If you faint, especially with exertion or a family history of sudden cardiac events, see a qualified provider first.
Frequently Asked Questions
Is fainting hereditary?
Vasovagal fainting has a real inherited component. Family and twin studies show that a first-degree relative who faints raises your own likelihood. A 2020 genome-wide study linked a variant near ZNF804A at chromosome 2q32.1 to vasovagal syncope, confirming a genetic contribution to reflex fainting.
Which genes are linked to fainting?
The best-established common signal is near ZNF804A at 2q32.1 for vasovagal syncope. Adrenergic receptor genes ADRB1 and ADRB2 influence autonomic tone, while heart-rhythm genes such as SCN5A, KCNQ1, and KCNH2 are tied to cardiac syncope, a distinct and more serious cause.
How can I prevent fainting episodes?
For vasovagal syncope, learn your warning signs and act early: hydrate, use physical counter-pressure maneuvers like leg-crossing or hand-clenching, avoid prolonged standing in heat, and follow provider guidance on salt and fluids. Any fainting during exertion needs prompt medical evaluation, not self-management.
Can a genetic test tell me if I will faint?
No. A genetic test describes pathway-level biology, not whether or when you will faint. Fainting is diagnosed and classified clinically by a qualified provider. Genetic context can add background, but it never predicts events or replaces cardiac and autonomic evaluation.
Curious how your own biology maps to these pathways? Take the Precision Peptide Genetic Test to see the pathway-level genetic context behind your results, then bring it to a qualified provider who knows your full picture.
This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
MTRR Gene Variant rs1801394: Health Risks Explained
Effects of PPARGC1A gene variant rs8192678 on athletic performance and diabetes risk?